Restore Mind Medicine

The Irrefutable Need For Change The current management's tenure at MindMed has been marked by apparent: → critical delays in clinical trials, →ill-conceived and botched regulatory strategies, → excessive spending and compensation, and destructive financings. x The Board has failed to provide real oversight and created an urgent need for change. The result: The massive destruction of value and the dramatic underperformance of the shares. FCM determined that the only way to put MindMed back on track and stop the destruction of further shareholder value would be to reconstitute the Board for the benefit of all shareholders. 11

View entire presentation